LIFD — LFTD PARTNERS INC.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1391135 ·
Last close
$0.11
Market Cap
$1.63M
52W High
$0.30
52W Low
$0.07
ADV30
437
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 8,705,194 | 651,233 | -1,579,903 | -1,438,290 | 12,026,907 | 1,504,297 | 4,999,579 |
| Mar 2026 | 9,158,206 | -1,706,080 | -4,015,518 | -4,159,949 | 14,451,380 | 2,091,129 | 5,982,395 |
| Dec 2025 | 8,414,871 | 2,999,373 | 95,138 | -24,920,943 | 19,272,548 | 1,767,123 | 6,640,288 |
| Sep 2025 | 9,056,742 | 4,157,495 | 1,890,751 | 634,257 | 44,943,570 | 1,920,664 | 7,386,963 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,139,275
Investing CF
$-176,086
Financing CF
$-2,574,944
CapEx
$-176,086
Dividends Paid
$-13,502
Buybacks
$0
EPS Diluted TTM
$-0.36
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-34,444,821
Inventory
$3,459,768
Receivables
$2,940,373
ST Investments
—
EBIT TTM
$-29,907,271
Pretax Income TTM
$-30,079,375
Interest Exp TTM
$172,104
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$35,335,012
EBITDA
$-3,392,543
Free Cash Flow
$2,281,615
Enterprise Value
$1,810,377
Total Cash
$1,504,297
Total Debt
$1,684,137
Shares Out
14,822,678
Trailing EPS
$-2.02
Book Value
$0.47
ROE
-136.0%
ROA
-8.2%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 36,920,799 | 2,076,497 | -24,858,678 | 19,272,548 | 6,640,288 | 12,632,260 | 1,321,503 |
| Dec 2024 | 37,325,228 | 1,266,159 | -1,857,429 | 47,619,830 | 10,115,389 | 37,504,441 | -960,067 |
| Dec 2023 | 51,610,562 | 3,358,636 | 2,159,007 | 51,346,651 | 12,528,639 | 38,818,012 | 638,925 |
| Dec 2022 | 57,416,535 | 10,368,902 | 7,196,327 | 41,132,221 | 6,594,548 | 34,537,673 | 3,037,426 |
TTM Snapshot
Revenues TTM
$35,335,013
NetIncome TTM
$-29,884,925
OpCashFlow TTM
—
Assets (Latest)
$12,026,907
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| EMMA | Emmaus Life Sciences, Inc. | $1.61M | $0.02 | — |
| ARTL | ARTELO BIOSCIENCES, INC. | $1.57M | $1.68 | — |
| RNAZ | Transcode Therapeutics, Inc. | $1.49M | $1.41 | — |
| HCWB | HCW Biologics Inc. | $1.43M | $0.78 | — |
| CPMD | CANNAPHARMARX, INC. | $1.42M | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
Lifted Made Completes $1.5 Million Sale of Kenosha Building and Repays all Outstanding Bank Debt
2026-10-01 10:30 · Yahoo
Highlandia Soars to Best in Show, Leads Four-Medal Sweep at 2026 Summer PR%F Awards as Brand Launches Two New THC Elixirs
2026-09-01 10:30 · Yahoo
Lifted’s Highlandia THC Beverage Becomes a Top-Five Seller in WI, and Plans Expansion Into Other States
2026-07-02 10:30 · Yahoo
Lifted Made Streamlines Operations
2026-06-30 10:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.